126 related articles for article (PubMed ID: 31913217)
1. INTRAVITREAL RANIBIZUMAB INJECTION AND RETINAL LASER PHOTOCOAGULATION TREATMENT FOR ADULT-ONSET COATS DISEASE.
Plaza-Laguardia C; Pascual-Camps I; Bayón-Porras MR; Sánchez-Cañizal J; Gallego-Pinazo R
Retin Cases Brief Rep; 2021 Sep; 15(5):532-535. PubMed ID: 31913217
[TBL] [Abstract][Full Text] [Related]
2. Combined treatment for Coats' disease: retinal laser photocoagulation combined with intravitreal bevacizumab injection was effective in two cases.
Kodama A; Sugioka K; Kusaka S; Matsumoto C; Shimomura Y
BMC Ophthalmol; 2014 Mar; 14():36. PubMed ID: 24666524
[TBL] [Abstract][Full Text] [Related]
3. Successful use of intravitreal ranibizumab injection and combined treatment in the management of Coats' disease.
Yang Q; Wei W; Shi X; Yang L
Acta Ophthalmol; 2016 Jun; 94(4):401-6. PubMed ID: 27150442
[TBL] [Abstract][Full Text] [Related]
4. The efficacy of conbercept or ranibizumab intravitreal injection combined with laser therapy for Coats' disease.
Zhang L; Ke Y; Wang W; Shi X; Hei K; Li X
Graefes Arch Clin Exp Ophthalmol; 2018 Jul; 256(7):1339-1346. PubMed ID: 29549425
[TBL] [Abstract][Full Text] [Related]
5. Intravitreal dexamethasone implant with retinal photocoagulation for adult-onset Coats' disease.
Kumar K; Raj P; Chandnani N; Agarwal A
Int Ophthalmol; 2019 Feb; 39(2):465-470. PubMed ID: 29380183
[TBL] [Abstract][Full Text] [Related]
6. Successful use of intravitreal bevacizumab and pascal laser photocoagulation in the management of adult Coats' disease.
Raoof N; Quhill F
Middle East Afr J Ophthalmol; 2013; 20(3):256-8. PubMed ID: 24014992
[TBL] [Abstract][Full Text] [Related]
7. Early onset coats' disease initially treated as unilateral ROP at 39 weeks postmenstrual age: a case report.
Peng J; Zhang Q; Chen C; Huang Q; Li Y; Zhao P
BMC Ophthalmol; 2017 Aug; 17(1):145. PubMed ID: 28814287
[TBL] [Abstract][Full Text] [Related]
8. Combined treatment with intravitreal bevacizumab and laser photocoagulation for exudative maculopathy in facioscapulohumeral muscular dystrophy.
Matos R; Beato J; Silva M; Silva S; Brandão E; Falcão-Reis F; Penas S
Ophthalmic Genet; 2017; 38(5):490-493. PubMed ID: 28121209
[TBL] [Abstract][Full Text] [Related]
9. Management of stage 3B Coats disease: presentation of a combined treatment modality and long-term follow-up.
Liang T; Peng J; Zhang Q; Zhu X; Xu Y; Zhao P
Graefes Arch Clin Exp Ophthalmol; 2020 Sep; 258(9):2031-2038. PubMed ID: 32474693
[TBL] [Abstract][Full Text] [Related]
10. INTRAVITREAL RANIBIZUMAB AS AN ADJUNCTIVE TREATMENT FOR COATS DISEASE (6-YEAR FOLLOW-UP).
Giannakopoulos M; Drimtzias E; Panteli V; Vasilakis P; Gartaganis SP
Retin Cases Brief Rep; 2017 Fall; 11(4):339-343. PubMed ID: 27472513
[TBL] [Abstract][Full Text] [Related]
11. The effects of a treatment combination of anti-VEGF injections, laser coagulation and cryotherapy on patients with type 3 Coat's disease.
Li S; Deng G; Liu J; Ma Y; Lu H
BMC Ophthalmol; 2017 May; 17(1):76. PubMed ID: 28532448
[TBL] [Abstract][Full Text] [Related]
12. [Adjuvant anti-VEGF therapy in Coats' disease].
Fiorentzis M; Stavridis E; Seitz B; Viestenz A
Ophthalmologe; 2015 May; 112(5):451-4. PubMed ID: 25134462
[TBL] [Abstract][Full Text] [Related]
13. Treatment of Advanced Coats' Disease With Combination Therapy of Laser Photocoagulation, Intravitreal Ranibizumab, and Sub-Tenon Methylprednisolone Acetate.
Petroni S; Catena G; Iarossi G; Federici M; Zinzanella G; Parrilla R; Valente P; Buzzonetti L
J Pediatr Ophthalmol Strabismus; 2022; 59(3):187-191. PubMed ID: 34928773
[TBL] [Abstract][Full Text] [Related]
14. Bevacizumab for Coats' disease with exudative retinal detachment and risk of vitreoretinal traction.
Ramasubramanian A; Shields CL
Br J Ophthalmol; 2012 Mar; 96(3):356-9. PubMed ID: 21653215
[TBL] [Abstract][Full Text] [Related]
15. TRANSCLERAL DRAINAGE OF SUBRETINAL FLUID, ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR, AND WIDE-FIELD IMAGING-GUIDED LASER IN COATS EXUDATIVE RETINAL DETACHMENT.
Stanga PE; Jaberansari H; Bindra MS; Gil-Martinez M; Biswas S
Retina; 2016 Jan; 36(1):156-62. PubMed ID: 26355946
[TBL] [Abstract][Full Text] [Related]
16. Visual outcomes after treatment in pediatric patients with Coats' disease.
Chiu HH; Wan MJ; Kertes PJ; Muni RH; Lam WC
Can J Ophthalmol; 2019 Dec; 54(6):647-652. PubMed ID: 31836093
[TBL] [Abstract][Full Text] [Related]
17. Combination treatment of pediatric coats' disease: a bicenter study in Taiwan.
Lin CJ; Chen SN; Hwang JF; Yang CM
J Pediatr Ophthalmol Strabismus; 2013; 50(6):356-62. PubMed ID: 24669373
[TBL] [Abstract][Full Text] [Related]
18. A combination of intravitreal bevacizumab injection with tunable argon yellow laser photocoagulation as a treatment for adult-onset Coats' disease.
Wang KY; Cheng CK
J Ocul Pharmacol Ther; 2011 Oct; 27(5):525-30. PubMed ID: 21951171
[TBL] [Abstract][Full Text] [Related]
19. Intravitreal bevacizumab injections combined with laser photocoagulation for adult-onset Coats' disease.
Park S; Cho HJ; Lee DW; Kim CG; Kim JW
Graefes Arch Clin Exp Ophthalmol; 2016 Aug; 254(8):1511-1517. PubMed ID: 26631136
[TBL] [Abstract][Full Text] [Related]
20. Resolution of Foveal Lipid Deposition in Adult-Onset Coats Disease With Combined Focal Laser Photocoagulation and Anti-VEGF Therapy.
Xu X; Essilfie J; Gong Y; Yu SQ; Freund KB
Ophthalmic Surg Lasers Imaging Retina; 2021 Jul; 52(7):396-399. PubMed ID: 34309430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]